Standard BioTools Inc. Increase (Decrease) in Other Operating Assets
Standard BioTools Inc. (LAB) reported Increase (Decrease) in Other Operating Assets of -$322.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2019-11-08
- Standard BioTools Inc. increase (decrease) in other operating assets for the quarter ending 2019-09-30 was -$18.00K, a 109.05% decline year-over-year.
- Standard BioTools Inc. increase (decrease) in other operating assets for the quarter ending 2019-06-30 was -$204.00K.
- Standard BioTools Inc. increase (decrease) in other operating assets for the quarter ending 2019-03-31 was -$100.00K.
- Standard BioTools Inc. increase (decrease) in other operating assets for the quarter ending 2018-09-30 was $199.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2019-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$222.00K derived: sum of 2 quarters · filed 2019-11-08 | -$322.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$304.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$100.00K 10-Q · filed 2019-05-07 | ||
| 2018-09-30 | $199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$539.00K derived: sum of 2 quarters · filed 2019-11-08 | -$622.00K 10-Q · filed 2019-11-08 |
| 2018-06-30 | -$738.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$821.00K 10-Q · filed 2019-08-07 | |
| 2018-03-31 | -$83.00K 10-Q · filed 2019-05-07 | ||
| 2017-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$2.41M derived: sum of 2 quarters · filed 2018-11-06 | -$1.42M 10-Q · filed 2018-11-06 |
| 2017-06-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.39M 10-Q · filed 2018-08-08 | |
| 2017-03-31 | $996.00K 10-Q · filed 2018-05-08 | ||
| 2016-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$43.00K derived: sum of 2 quarters · filed 2017-11-07 | $84.00K 10-Q · filed 2017-11-07 |
| 2016-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $133.00K 10-Q · filed 2017-08-08 | |
| 2016-03-31 | $127.00K 10-Q · filed 2017-05-09 | ||
| 2015-09-30 | -$47.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $266.00K derived: sum of 2 quarters · filed 2016-11-09 | $116.00K 10-Q · filed 2016-11-09 |
| 2015-06-30 | $313.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $163.00K 10-Q · filed 2016-08-09 | |
| 2015-03-31 | -$150.00K 10-Q · filed 2016-05-09 | ||
| 2014-09-30 | -$499.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$2.44M derived: sum of 2 quarters · filed 2015-11-09 | $662.00K 10-Q · filed 2015-11-09 |
| 2014-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.16M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $3.10M 10-Q · filed 2015-05-11 | ||
| 2013-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $20.00K derived: sum of 2 quarters · filed 2014-11-06 | $7.00K 10-Q · filed 2014-11-06 |
| 2013-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $9.00K 10-Q · filed 2014-08-04 | |
| 2013-03-31 | -$13.00K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |